Back to results

Medical University of Varna

Treatment of Medication-Induced Osteonecrosis of the Jaws, Using Platelet-Rich Fibrin PRF // Лечение на медикаментозно-индуцирана остеонекроза на челюстите с приложение на богат на тромбоцити фибрин PRF

Abstract

dc:description

Medication-induced osteonecrosis of the jaws (MRONJ) in an area of exposed bone, which does not heal in a period of more than eight weeks and affects patients underdoing medication therapy. These are mostly patients diagnosed with cancer and on intravenous treatment. The impact of the disease globally increases with the increase of medication prescribed. Currently, the treatment of MRONJ is still problematic, as effective treatment has not yet been developed. Surgical treatment is still one of the most trusted methods, although current updates are much needed, by means of scientific progress and technical advancement, which provide relatively easy application of growth factors in the field of oral and maxillofacial surgery. One of these advancements is the Platelet-rich Fibrin membrane, which could easily be obtained (extracted) in ambulatory conditions. Application of PRF in surgery is an alternative method of MIONJ treatment. Doham et al.(2006) develop an extraction protocol for PRF.

Degree

thesis:*
Grantor dc:publisher
Medical University of Varna
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Tsolov, Rosen
  • Цолов, Росен

Subjects

dc:subject × 4

Identifiers

dc:identifier.*
Repository record dc:identifier
http://repository.mu-varna.bg/handle/nls/1851
OAI identifier oai:identifier
oai:repository.mu-varna.bg:nls/1851

Chain of custody

source
Harvested from
Medical University of Varna
Base URL
repository.mu-varna.bg/oai/request
Last updated
2026-07-27
Source record
OAI-PMH GetRecord
citation

Tsolov, Rosen; Цолов, Росен. Treatment of Medication-Induced Osteonecrosis of the Jaws, Using Platelet-Rich Fibrin PRF // Лечение на медикаментозно-индуцирана остеонекроза на челюстите с приложение на богат на тромбоцити фибрин PRF. Medical University of Varna, 2022. http://repository.mu-varna.bg/handle/nls/1851